RheumNow

Detection, Monitoring & Management of Autoimmune ILD jjcush@gmail.com Mon, 09/29/2025 – 08:00 Read More

Our final webinar in this month’s Rheum to Breathe: ILD campaign brings together ILD experts to discuss… Read More

🆕 ILD (Part III): clinical practice focus 🔬 Diagnostic challenges 🧑⚕️ Case-based learning 📈 Evidence &a https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg… Read More

QD Clinic: ILD with Positive SSA and Rash Dr. Elena Joerns, Rochester, Minnesota discusses a case of… Read More

ILD and ANCA: What to do? Several cohort studies conducted in Asia, Europe and the Americas have… Read More

Rheum to Breathe Journal Club In this journal club, we will discuss two pivotal studies in ILD,… Read More

HLA-B27: still the most important genetic factor in axSpA susceptibility, but has lower frequency African American, Sout… Read More

Screening for RA-ILD: metanalysis of 9 studies, 1380 RA pts – RA-ILD prevalence ranged from 6.7-42.7%; 18.9%… Read More

How Does Your Garden Grow (0.26.2025) jjcush@gmail.com Fri, 09/26/2025 – 12:30 Read More

CAR-T Product Shows Early Promise in Lupus Five patients with systemic lupus erythematosus (SLE) in China have… Read More

What is IPAF? Janet.Pope@sjh… Fri, 09/26/2025 – 08:00 Read More

PPP syndrome = a rare triad 👉 Pancreatitis + Polyarthritis + Panniculitis 🔬 Pathogenesis: circulating pancreatic https://pbs.twimg.com/profile_images/1815290761296097280/FLR44mP7_normal.jpg… Read More

High-Resolution CT in CTD-Interstitial Lung Disease A systematic review and meta-analysis examined the role of high-re https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg… Read More

Inception SLE study of 674 pts (without LN), mean age 34 yrs – 154 (23%) developed new… Read More

Polypharmacy Impairs Rheumatoid Arthritis Outcomes jjcush@gmail.com Thu, 09/25/2025 – 17:57 Read More

OL study of 60 pts w/ new idiopathic retroperitoneal fibrosis (GFR >30) Rx w/ low dose MTX+pred… Read More

Final session alert! Join us for the closing webinar of our Rheum to Breathe: ILD campaign. ILD… Read More

Turkish study of 799 psoriasis pts – 30% had concurrent onset PsO & PsA & in 70%… Read More

Malignancies Not Increased with Biologic Therapies jjcush@gmail.com Thu, 09/25/2025 – 11:38 Read More

Canakinumab in VEXAS – 47 males Rx w/ anakinra (44), canakinumab (9), or both(6). Response @1 mos:… Read More

Prospective French study of 101 RA-ILD (mean 66yrs) assessed for shorter WBC telomere length (LTL); short LTL… Read More

Rheumatoid arthritis begins long before symptoms jjcush@gmail.com Wed, 09/24/2025 – 19:27 Read More

Monthly survey – 351 ArthritisPower #RA Registry pts reported 523 nonserious infxns (31% ; most URI), few… Read More